Answer
It is targeted therapy: a selective inhibitor of the MEK1 and MEK2 signalling proteins.
Sources for this answer
- Koselugo 25 mg hard capsules — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.